INTS Q1 2026 Earnings NarrowerThanExpected Loss as PreRevenue Biotech Advances Clinical Pipeline CRBP Q1 2026 Earnings Narrower Loss Beats Estimates but No Revenue and Sharp Share Decline Raise Concerns BBLG Q1 2026 Earnings EPS Surprises to the Upside Despite No Revenue Stock Declines LNZA Q4 2025 Earnings EPS Surprise Beats Estimate by Wide Margin Yet Stock Falls Ovintiv OVV Q1 2026 Earnings EPS Beats Estimates by 669 Amid Operational Efficiency CBRL Q1 2026 Earnings Significant EPS Beat Surprises Market